Pacira BioSciences Inc (USD)
PCRX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range45.09 | 45.88
52-Wk Range34.64 | 49.50
Last Close45.68
Mkt Cap (m)1,906.26
Dividend yield-
ISINUS6951271005
Volume460,319
Exchange VenueNAS

Company Profile

Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.

Key Information
Price/Earning913.60
Price/Book5.51
Price/Sales4.80
P/CF28.69
Rev Growth (3 year avg)10.64
EPS Growth (3 year avg)-
Operating Margin % 5.18
Net Margin %-0.14
Return on Equity-0.16
Debt/Equity0.91

Legal Documents

Prospectus
en 09/04/2014
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)86198249276287337
Operating Income (m)-53-59-32-2017
Net Income (m)-64-142-38-43
Basic EPS-1.93-0.390.05-1.02-1.07-0.01
Avg. Diluted Shares Outstanding (m)333541374041
Balance Sheet
USD201320142015201620172018
Current Assets (m)107214253243391478
Non Current Assets (m)63112137148237211
Total Assets (m)170326390391628689
Current Liabilities (m)122140152455661
Total Liabilities (m)------
Total Equity (m)41171218219279321
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-432529331849
Capital Expenditure (m)-13-22-41-25-19-15
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
45.68
Last Price